139 related articles for article (PubMed ID: 37519006)
1. ELK4 Promotes Cell Cycle Progression and Stem Cell-like Characteristics in HPV-associated Cervical Cancer by Regulating the FBXO22/PTEN Axis.
Gao F; Wang C; Bai X; Ji J; Huang X
Balkan Med J; 2023 Oct; 40(6):409-414. PubMed ID: 37519006
[TBL] [Abstract][Full Text] [Related]
2. miR-129-5p inhibits anchorage-independent growth through silencing of ACTN1 and the ELK4/c-FOS axis in HPV-transformed keratinocytes.
Huseinovic A; Xu M; Jaspers A; Bais B; Steenbergen RDM
J Med Virol; 2024 Apr; 96(4):e29580. PubMed ID: 38566572
[TBL] [Abstract][Full Text] [Related]
3. Fbxo22 promotes cervical cancer progression via targeting p57
Lin M; Zhang J; Bouamar H; Wang Z; Sun LZ; Zhu X
Cell Death Dis; 2022 Sep; 13(9):805. PubMed ID: 36127346
[TBL] [Abstract][Full Text] [Related]
4. HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.
Wang J; Xiang F; Liu X; Ma X; Cai X; Yang Y; Shen X; Yuan C; Xiang Y; Xiao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760214
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
[TBL] [Abstract][Full Text] [Related]
6. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
7. Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.
Hu T; Li YS; Chen B; Chang YF; Liu GC; Hong Y; Chen HL; Xiyang YB
Exp Biol Med (Maywood); 2015 Oct; 240(10):1287-97. PubMed ID: 25616277
[TBL] [Abstract][Full Text] [Related]
8. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG8 accelerates proliferation and inhibits apoptosis in HPV-induced cervical cancer through recruiting EZH2 to epigenetically silence RECK expression.
Qu X; Li Y; Wang L; Yuan N; Ma M; Chen Y
J Cell Biochem; 2020 Oct; 121(10):4120-4129. PubMed ID: 31961005
[TBL] [Abstract][Full Text] [Related]
10. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m
Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K
Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
Chi Y; Shi L; Lu S; Cui H; Zha W; Shan L; Shen Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):116969. PubMed ID: 37516391
[TBL] [Abstract][Full Text] [Related]
12. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0000730 restrains cell proliferation, migration, and invasion in cervical cancer through miR-942-5p/PTEN axis.
Yuan DD; Jia CD; Yan MY; Wang J
Kaohsiung J Med Sci; 2021 Nov; 37(11):964-972. PubMed ID: 34562344
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
Wei XM; Wang Q; Gao SJ; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578
[TBL] [Abstract][Full Text] [Related]
15. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
[TBL] [Abstract][Full Text] [Related]
16. Interaction of miR-200a-3p with YAP regulates cell proliferation and metastasis differentially in HPV-positive and HPV-negative cervical cancer cells.
Chen H; Gu L; Zhang M; Chen H; Liao H; Cao X; Yu L; Zhang J
BMC Cancer; 2022 Oct; 22(1):1039. PubMed ID: 36195847
[TBL] [Abstract][Full Text] [Related]
17. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
18. The expression and significance of lncRNA HOST2 and microRNA let-7b in HPV-positive cervical cancer tissues and cell lines.
Zhang Y; Jia LG; Wang P; Li J; Tian F; Chu ZP; Kang S
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2380-2390. PubMed ID: 30964163
[TBL] [Abstract][Full Text] [Related]
19. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis.
Du Y; Geng G; Zhao C; Gao T; Wei B
BMC Cancer; 2022 Nov; 22(1):1145. PubMed ID: 36344947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
